The in vivo anticancer efficacy of CCG-257081 was assessed in a murine model, employing immunohistochemistry labeling of tumor tissue to examine alterations in critical markers, including Ki-67 and cleaved caspase-3. This evidence concerns the gene MKI67 and neoplasm.